Profund Advisors’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$804K Sell
54,018
-37,242
-41% -$401K 0.02% 404
2026
Q1
$772K Buy
91,260
+13,981
+18% +$153K 0.03% 417
2025
Q4
$872K Buy
77,279
+41,881
+118% +$519K 0.03% 381
2025
Q3
$531K Buy
35,398
+9,634
+37% +$140K 0.02% 495
2025
Q2
$364K Buy
25,764
+478
+2% +$8.52K 0.01% 586
2025
Q1
$608K Sell
25,286
-1,471
-5% -$51.9K 0.03% 418
2024
Q4
$999K Sell
26,757
-831
-3% -$38.8K 0.04% 298
2024
Q3
$1.38M Sell
27,588
-8,651
-24% -$337K 0.05% 256
2024
Q2
$1.26M Buy
36,239
+10,786
+42% +$426K 0.05% 259
2024
Q1
$1.39M Sell
25,453
-19,060
-43% -$944K 0.05% 261
2023
Q4
$1.91M Sell
44,513
-13,001
-23% -$404K 0.08% 179
2023
Q3
$1.5M Buy
57,514
+22,695
+65% +$472K 0.08% 187
2023
Q2
$833K Sell
34,819
-31,189
-47% -$537K 0.04% 362
2023
Q1
$902K Buy
+66,008
New +$1.05M 0.06% 324

Other funds holding BHVN

Profund Advisors's BHVN Position: Q2 2026 in Review

Profund Advisors reduced its Biohaven (BHVN) stake by 41% in Q2 2026, selling an estimated $401K and leaving 54,018 shares worth $804K. The position accounts for 0.02% of the portfolio, ranked #404.

Profund Advisors first reported a position in BHVN in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.91M in Q4 2023. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Profund Advisors held 54,018 shares of Biohaven worth $804K as of Q2 2026.
  • Profund Advisors sold 37,242 Biohaven shares in Q2 2026, an estimated $401K.
  • Biohaven made up 0.02% of Profund Advisors's portfolio in Q2 2026, its #404 holding.
  • Profund Advisors first reported a position in Biohaven in Q1 2023 and has held it in 14 quarters since.
  • Profund Advisors's Biohaven position peaked at $1.91M in Q4 2023.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.